Showing results (381-390 of 432) with videos related to
Sort By:
Pageof 44
Journal of Chemical Information and Modeling|May 10, 2024
Machine Learning Models Identify Inhibitors of New Delhi Metallo-β-lactamaseZishuo Cheng, Mahesh Aitha, Caitlyn A Thomas, et al.Journal of Biomolecular Screening|July 28, 2016
Development of a High-Throughput Gene Expression Screen for Modulators of RAS-MAPK Signaling in a Mutant RAS Cellular ContextBryan Severyn, Thi Nguyen, Michael D Altman, et al.Oncogene|March 1, 2018
Functional screening of FGFR4-driven tumorigenesis identifies PI3K/mTOR inhibition as a therapeutic strategy in rhabdomyosarcomaTimothy McKinnon, Rosemarie Venier, Marielle Yohe, et al.Molecular and Cellular Biology|September 27, 2006
Small interfering RNA screens reveal enhanced cisplatin cytotoxicity in tumor cells having both BRCA network and TP53 disruptionsSteven R Bartz, Zhan Zhang, Julja Burchard, et al.Developmental Cell|September 3, 2013
A TRP channel in the lysosome regulates large particle phagocytosis via focal exocytosisMohammad Samie, Xiang Wang, Xiaoli Zhang, et al.Analytical Biochemistry|July 3, 2007
A high-precision fluorogenic cholesteryl ester transfer protein assay compatible with animal serum and 3456-well assay technologySuzanne S Eveland, Denise P Milot, Qiu Guo, et al.Cancer Chemotherapy and Pharmacology|October 12, 2018
Pharmacokinetic evaluation of the PNC disassembler metarrestin in wild-type and Pdx1-Cre;LSL-KrasG12D/+;Tp53R172H/+ (KPC) mice, a genetically engineered model of pancreatic cancerTomas Vilimas, Amy Q Wang, Samarjit Patnaik, et al.Nature|February 7, 2022
Pyrimidine inhibitors synergize with nucleoside analogues to block SARS-CoV-2David C Schultz, Robert M Johnson, Kasirajan Ayyanathan, et al.Nature Methods|December 22, 2022
Bioprinted 3D outer retina barrier uncovers RPE-dependent choroidal phenotype in advanced macular degenerationMin Jae Song, Russ Quinn, Eric Nguyen, et al.FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|August 17, 2019
Therapeutic effects of a small molecule agonist of the relaxin receptor ML290 in liver fibrosisElena M Kaftanovskaya, Hooi Hooi Ng, Mariluz Soula, et al.Pageof 44